Rigel Pharmaceuticals Inc (RIGL)
0.9844
-0.04
(-3.49%)
USD |
NASDAQ |
May 10, 16:00
0.9844
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals Revenue (Quarterly): 35.79M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 35.79M |
| September 30, 2023 | 28.13M |
| June 30, 2023 | 26.89M |
| March 31, 2023 | 26.07M |
| December 31, 2022 | 51.28M |
| September 30, 2022 | 22.41M |
| June 30, 2022 | 29.82M |
| March 31, 2022 | 16.74M |
| December 31, 2021 | 20.41M |
| September 30, 2021 | 21.54M |
| June 30, 2021 | 26.27M |
| March 31, 2021 | 81.02M |
| December 31, 2020 | 18.45M |
| September 30, 2020 | 18.39M |
| June 30, 2020 | 16.02M |
| March 31, 2020 | 55.76M |
| December 31, 2019 | 15.40M |
| September 30, 2019 | 20.86M |
| June 30, 2019 | 10.41M |
| March 31, 2019 | 12.62M |
| December 31, 2018 | 37.86M |
| September 30, 2018 | 4.865M |
| June 30, 2018 | 1.787M |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.90M |
| June 30, 2017 | |
| March 31, 2017 | 3.584M |
| December 31, 2016 | 3.00M |
| September 30, 2016 | 3.76M |
| June 30, 2016 | 8.594M |
| March 31, 2016 | 5.029M |
| December 31, 2015 | 8.537M |
| September 30, 2015 | 13.00M |
| June 30, 2015 | 5.184M |
| March 31, 2015 | 2.178M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 5.75M |
| September 30, 2013 | |
| June 30, 2013 | 1.40M |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | 1.50M |
| March 31, 2012 | 0.75M |
| December 31, 2011 | |
| September 30, 2011 | 4.355M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
10.41M
Minimum
Jun 2019
81.02M
Maximum
Mar 2021
28.51M
Average
22.41M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
| Nektar Therapeutics | 23.88M |
| Avid Bioservices Inc | 33.82M |
| Stereotaxis Inc | 4.565M |
| Cara Therapeutics Inc | 3.004M |
| Ardelyx Inc | 46.02M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.737M |
| Total Expenses (Quarterly) | 33.83M |
| EPS Diluted (Quarterly) | 0.01 |
| Enterprise Value | 181.55M |
| Gross Profit Margin (Quarterly) | 89.41% |
| Profit Margin (Quarterly) | 2.06% |
| Earnings Yield | -14.22% |
| Normalized Earnings Yield | -14.22 |